Accepted for Publication: March 22, 2013.
Published Online: July 15, 2013. doi:10.1001/jamainternmed.2013.7734.
Acquisition of data: Reuter, Ellington, Cartwright, Köser, Török, Gouliouris, Brown, Quail, Smith, Bentley, Peacock.
Analysis and interpretation of data: Reuter, Ellington, Cartwright, Köser, Török, Gouliouris, Harris, Holden, Parkhill, Bentley, Peacock.
Drafting of the manuscript: Reuter, Ellington, Cartwright, Köser, Török, Gouliouris, Holden, Bentley, Peacock.
Critical revision of the manuscript for important intellectual content: Reuter, Ellington, Köser, Harris, Brown, Holden, Quail, Parkhill, Smith, Bentley, Peacock.
Obtained funding: Parkhill, Smith, Bentley, Peacock.
Administrative, technical, and material support: Reuter, Ellington, Cartwright, Harris, Brown, Quail, Smith, Peacock.
Study supervision: Ellington, Török, Holden, Parkhill, Bentley, Peacock.
Conflict of Interest Disclosures: Dr Ellington was funded by Bruker Daltonics to attend a conference. Dr Török has received speaker honoraria and book royalties from Oxford University Press and funding for travel and accommodation from Illumina Inc. Dr Brown is a consultant for Astellas Pharma Ltd and Discuva Ltd. Dr Smith is an employee and shareholder of Illumina Inc. Dr Parkhill has received funding for travel and accommodation from Pacific Biosciences Inc. and Illumina Inc. Dr Peacock is a consultant for Pfizer Inc.
Funding/Support: This work was supported by grants from the UKCRC Translational Infection Research Initiative and the Medical Research Council (G1000803) with contributions to the grant from the Biotechnology and Biological Sciences Research Council, the National Institute for Health Research on behalf of the Department of Health, and the Chief Scientist Office of the Scottish Government Health Directorate (Peacock); the Wellcome Trust (098051) awarded to the Wellcome Trust Sanger Institute; Public Health England (Peacock); and the NIHR Cambridge Biomedical Research Centre (Cartwright, Török, Bentley, Peacock).